How many vaccines are currently under trial in India? In what stages are they now?
Ans. A memorandum of understanding has been signed between government of India, NACO, ICMR and the IAVI to develop HIV vaccine relevant to the HIV 1 c subtype most prevalent in our country. This is a modified Vaccinia Ankara version developed jointly between Indian Scientists and Therion Biologics USA. The candidate vaccine has been developed an is currently undergoing pre-clinical safety trial. After successful completion of these trials the Phase I clinical trials will be started in India. Research is also on at the Tuberculosis Research Centre, Chennai and the All India Institute of Medical Sciences with technical assistance from department of Bio-technology, Government of India. But these are at the initial stages of development.
Ans. A memorandum of understanding has been signed between government of India, NACO, ICMR and the IAVI to develop HIV vaccine relevant to the HIV -1 c subtype most prevalent in our country. This is a modified Vaccinia Ankara version developed jointly between Indian Scientists and Therion Biologics USA. The candidate vaccine has been developed an is currently undergoing pre-clinical safety trial. After successful completion of these trials the Phase I clinical trials will be started in India. Research is also on at the Tuberculosis Research Centre, Chennai and the All India Institute of Medical Sciences with technical assistance from department of Bio-technology, Government of India. But these are at the initial stages of development.
